Transcriptomic Insight and Structural Integration: Repositioning FDA-Approved Methotrexate Derivative for Precision Therapy in Lung Cancer through Drug-Drug Similarity Analysis and Cavity-Guided Blind Docking
Abstract In the pursuit of advancing precision therapy for lung cancer, this study explores the repositioning potential of a FDA approved methotrexate derivative, with a specific focus on its interaction with the Dihydrofolate Reductase (DHFR) enzyme. Leveraging transcriptomic insights and structural integration, our research employs a multifaceted approach, encompassing drug-drug similarity analysis and cavity-guided blind […]